Zimbabwe has turned down a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of the United States' demand for confidential biological samples.
The decision became public after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesman later clarified that the US was seeking genetic material for research and commercial purposes while refused to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further dialogue to reach a agreement acceptable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Background
This development follows a comparable situation in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the security of citizens' health data.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and accountability.
Based on statements, Sixteen African countries have to date signed similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its biological resources and data for a long time, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our nation would supply the raw materials for medical research with no certainty that the end products would be available to our people should a future health crisis emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining structures previously established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This framework is designed to guarantee that when a nation contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the independence and interests of each country."
Medical Community Response
Medical experts stated it understood the official position, but suggested that talks must proceed given that a large portion of the country's Aids initiatives relied on international support.
"If specific concerns exist, including those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," it said.
The situation underscores the continuing challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.